Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

ATNM — Actinium Pharmaceuticals, Inc. Dilution Risk Tracker

Track ATNM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ATNM — Get alerts when the score changes →

As of August 28, 2026, Actinium Pharmaceuticals, Inc. (ATNM) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Actinium Pharmaceuticals, Inc. has a market capitalization of $39.53M, 31.44M shares outstanding, 58 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.18 approaching $1 threshold
🔔 Track ATNM — Get forecast alerts →

Market Data

Market Cap$39.53M
Shares Outstanding31.44M
Float31.04M
Cash$36.47M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 28.1% shares (2026Q1 vs prior)
58 institutional holders · 7.13M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.51M shares
#2 ACADIAN ASSET MANAGEMENT LLC 600.8K shares
#3 MILLENNIUM MANAGEMENT LLC 564.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest787.0K
Days to Cover10.3
% of Float2.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2012-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ATNM Dilution Snapshot

Actinium Pharmaceuticals, Inc. (ATNM) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ATNM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATNM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ATNM
ATNM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.